ExodusPoint Capital Management, LP - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 247 filers reported holding NEKTAR THERAPEUTICS in Q1 2022. The put-call ratio across all filers is 1.00 and the average weighting 0.0%.

Quarter-by-quarter ownership
ExodusPoint Capital Management, LP ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q4 2022$1,113
-98.9%
492,500
+1486.2%
0.02%
+1500.0%
Q3 2022$99,000
-95.6%
31,049
-92.5%
0.00%
-96.4%
Q1 2022$2,241,000
+694.7%
415,709
+1890.6%
0.03%
+833.3%
Q4 2021$282,000
-72.3%
20,884
-63.2%
0.00%
-78.6%
Q3 2021$1,019,000
+38.3%
56,756
+32.1%
0.01%
+75.0%
Q2 2021$737,000
+162.3%
42,964
+159.7%
0.01%
+166.7%
Q4 2020$281,000
-66.5%
16,544
-67.2%
0.00%
-82.4%
Q3 2020$838,000
+1.7%
50,503
+42.0%
0.02%
-19.0%
Q2 2020$824,000
-7.5%
35,558
-13.9%
0.02%
+23.5%
Q4 2019$891,00041,2790.02%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q1 2022
NameSharesValueWeighting ↓
Strong Tower Advisory Services 404,972$6,913,0004.02%
GREAT POINT PARTNERS LLC 504,691$9,064,0002.11%
Camber Capital Management LP 3,750,000$67,350,0002.07%
ACT CAPITAL MANAGEMENT, LLC 161,500$2,901,0001.50%
Rhenman & Partners Asset Management AB 950,000$17,062,0001.20%
MAVERICK CAPITAL LTD 5,838,426$104,858,0001.06%
Birchview Capital, LP 72,000$1,293,0000.88%
Bellevue Group AG 4,594,656$82,519,0000.84%
CM Management, LLC 50,000$898,0000.67%
Duquesne Family Office 1,000,000$17,960,0000.58%
View complete list of NEKTAR THERAPEUTICS shareholders